Romani A, Lodi G, Casciano F, Gonelli A, Secchiero P, Zauli G
Cells. 2024; 13(20.
PMID: 39451196
PMC: 11506859.
DOI: 10.3390/cells13201678.
Wang W, Albadari N, Du Y, Fowler J, Sang H, Xian W
Pharmacol Rev. 2024; 76(3):414-453.
PMID: 38697854
PMC: 11068841.
DOI: 10.1124/pharmrev.123.001026.
Perez J, Perez R, Perez A
Front Mol Biosci. 2021; 8:681617.
PMID: 34095231
PMC: 8173110.
DOI: 10.3389/fmolb.2021.681617.
Brancaccio D, Di Maro S, Cerofolini L, Giuntini S, Fragai M, Luchinat C
ACS Med Chem Lett. 2020; 11(5):1047-1053.
PMID: 32435424
PMC: 7236535.
DOI: 10.1021/acsmedchemlett.9b00620.
Li W, Zhang X, Xi X, Li Y, Quan H, Liu S
Cancer Med. 2020; 9(12):4371-4385.
PMID: 32349184
PMC: 7300400.
DOI: 10.1002/cam4.3066.
Novel strategies for the treatment of myelofibrosis driven by recent advances in understanding the role of the microenvironment in its etiology.
Eran Z, Zingariello M, Bochicchio M, Bardelli C, Migliaccio A
F1000Res. 2019; 8.
PMID: 31583083
PMC: 6758840.
DOI: 10.12688/f1000research.18581.1.
Synthesis, Biological and In Silico Evaluation of Pure Nucleobase-Containing Spiro (Indane-Isoxazolidine) Derivatives as Potential Inhibitors of MDM2-p53 Interaction.
Maiuolo L, Algieri V, Russo B, Tallarida M, Nardi M, Di Gioia M
Molecules. 2019; 24(16).
PMID: 31405162
PMC: 6719244.
DOI: 10.3390/molecules24162909.
Identification of selective protein-protein interaction inhibitors using efficient peptide-directed ligand design.
Beekman A, Cominetti M, Walpole S, Prabhu S, OConnell M, Angulo J
Chem Sci. 2019; 10(16):4502-4508.
PMID: 31057779
PMC: 6482886.
DOI: 10.1039/c9sc00059c.
Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2-p53 Interaction in Mucoepidermoid Carcinoma.
Andrews A, Warner K, Rodriguez-Ramirez C, Pearson A, Nor F, Zhang Z
Clin Cancer Res. 2018; 25(5):1588-1600.
PMID: 30498096
PMC: 6397688.
DOI: 10.1158/1078-0432.CCR-17-2730.
The Satellite Cell Niche Regulates the Balance between Myoblast Differentiation and Self-Renewal via p53.
Flamini V, Ghadiali R, Antczak P, Rothwell A, Turnbull J, Pisconti A
Stem Cell Reports. 2018; 10(3):970-983.
PMID: 29429962
PMC: 5918193.
DOI: 10.1016/j.stemcr.2018.01.007.
MDM2 binding protein as a predictor of metastasis and a novel prognostic biomarker in patients with gastric cancer.
Wang W, Chen Z, Jin J, Long Z, Liu X, Cai H
Oncol Lett. 2018; 14(6):6409-6416.
PMID: 29422956
PMC: 5770606.
DOI: 10.3892/ol.2017.7031.
Discovery of 4-((3'R,4'S,5'R)-6″-Chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2″-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3″-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double....
Aguilar A, Lu J, Liu L, Du D, Bernard D, McEachern D
J Med Chem. 2017; 60(7):2819-2839.
PMID: 28339198
PMC: 5394527.
DOI: 10.1021/acs.jmedchem.6b01665.
Tumor-Suppressor Functions of the TP53 Pathway.
Aubrey B, Strasser A, Kelly G
Cold Spring Harb Perspect Med. 2016; 6(5).
PMID: 27141080
PMC: 4852799.
DOI: 10.1101/cshperspect.a026062.
The Roles of MDM2 and MDMX in Cancer.
Karni-Schmidt O, Lokshin M, Prives C
Annu Rev Pathol. 2016; 11:617-44.
PMID: 27022975
PMC: 6028239.
DOI: 10.1146/annurev-pathol-012414-040349.
PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.
Hu Z, Liao X, Xu Z, Yang X, Dong C, Jin A
Cancer Med. 2015; 5(1):74-87.
PMID: 26625870
PMC: 4708894.
DOI: 10.1002/cam4.558.
Direct and Propagated Effects of Small Molecules on Protein-Protein Interaction Networks.
Cesa L, Mapp A, Gestwicki J
Front Bioeng Biotechnol. 2015; 3:119.
PMID: 26380257
PMC: 4547496.
DOI: 10.3389/fbioe.2015.00119.
Discovery of Novel Isatin-Based p53 Inducers.
Davidovich P, Aksenova V, Petrova V, Tentler D, Orlova D, Smirnov S
ACS Med Chem Lett. 2015; 6(8):856-60.
PMID: 26288684
PMC: 4538431.
DOI: 10.1021/acsmedchemlett.5b00011.
Cordyceps militaris (L.) Link Fruiting Body Reduces the Growth of a Non-Small Cell Lung Cancer Cell Line by Increasing Cellular Levels of p53 and p21.
Bizarro A, Ferreira I, Sokovic M, Van Griensven L, Sousa D, Vasconcelos M
Molecules. 2015; 20(8):13927-40.
PMID: 26263965
PMC: 6332316.
DOI: 10.3390/molecules200813927.
Drug-eluting microarrays to identify effective chemotherapeutic combinations targeting patient-derived cancer stem cells.
Carstens M, Fisher R, Acharya A, Butterworth E, Scott E, Huang E
Proc Natl Acad Sci U S A. 2015; 112(28):8732-7.
PMID: 26124098
PMC: 4507198.
DOI: 10.1073/pnas.1505374112.
Nutlin-3 down-regulates retinoblastoma protein expression and inhibits muscle cell differentiation.
Walsh E, Niu M, Bergholz J, Xiao Z
Biochem Biophys Res Commun. 2015; 461(2):293-9.
PMID: 25871794
PMC: 4454893.
DOI: 10.1016/j.bbrc.2015.04.024.
